Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45

References

• United Nations Office on Drugs and Crime (UNODC). The challenge of new psychoactive substances. Available from: http://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf (Last accessed 14th October 2014).
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. 2014 European Drug Report: Trends and developments. Available from: www.emcdda.europa.eu/attachements.cfm/att_228272_EN_TDAT14001ENN.pdf (Last accessed 14th October 2014).
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol. EMCDDA–Europol Joint Report on a new psychoactive substance: AH-7921. Available from: www.emcdda.europa.eu/publications/joint-report/AH-7921 (Last accessed 17th September 2014).
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Report on the risk assessment of 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921) in the framework of the Council Decision on new psychoactive substances. Available from: http://www.emcdda.europa.eu/publications/risk-assessment/AH-7921 (Last accessed 14th October 2014).
   Google Scholar
• European Patent Office. 1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives and their salts and the preparation thereof. US Patent 3,957,788. Issued 18th May 1976. Available from: http://worldwide.espacenet.com/publicationDetails/biblio;jsessionid = D7CD40ECCEEFC5D97B47A2A07311908C.espacenet_levelx_prod_3? FT = D&date = 19760518&DB = &locale = en_EP&CC = US&NR = 3957788A&KC = A&ND = 1 (Last accessed 14th October 2014).
   Google Scholar
• Natsuka K, Nakamura H, Uno H, Umemoto S. Studies on 1-substituted 4-(1,2-diphenylethyl) piperazine derivatives and their analgesic activities. J Med Chem 1975; 18:1240–1244.
   PubMed Web of Science ®Google Scholar
• Natsuka K, Nakamura H, Nishikawa Y, Negoro T, Uno H, Nishimura H. Synthesis and structure–activity relationships of 1-substituted 4- (1,2-diphenylethyl) piperazine derivatives having narcotic agonist and antagonist activity. J Med Chem 1987; 30:1779–1787.
   PubMed Web of Science ®Google Scholar
• Fujimura H, Tsurumi K, Nozaki M, Hori M, Imai E. Analgesic activity and opiate receptor binding of 1-cyclohexyl-4-(1,2- Diphenylethyl) Piperazine. Jpn J Pharmacol 1978; 28:505–506.
   PubMedGoogle Scholar
• Nakamura H, Shimizu M. Comparative study of 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine (MT-45) and its enantiomorphs on analgesic and other pharmacological activities in experimental animals. Arch Int Pharmacodyn Thér 1976; 221:105–121.
   PubMedGoogle Scholar
• Nozaki M, Niwa M, Imai E, Hori M, Fujimura H. (1,2-Diphenylethyl) piperazines as potent opiate-like analgesics: the unusual relationships between stereoselectivity and affinity to opioid receptor. Life Sci 1983; 33:431–434.
   PubMed Web of Science ®Google Scholar
• Matsuno K, Senda T, Kobayashi T, Murai M, Mita S. Reduction of 4-cyclohexyl-1-[(1R)-1,2-diphenylethyl]-piperazine-induced memory impairment of passive avoidance performance by σ1 receptor agonists in mice. Methods Find Exp Clin Pharmacol 1988; 20:575–580.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Action on new drugs. Available from: www.emcdda.europa.eu/activities/action-on-new-drugs (Last accessed 14th October 2014).
   Google Scholar
• Wood DM, Dargan PI. Novel psychoactive substances: how to understand the toxicity (harm) associated with the use of these substances. Ther Drug Monit 2012; 34:363–367.
   PubMed Web of Science ®Google Scholar
• Wood DM, Dargan PI. Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs. J Med Toxicol 2012; 8:300–303.
   PubMedGoogle Scholar
• Wood DM, Dargan PI. Use and acute toxicity associated with the novel psychoactive substances diphenolprolinol (D2PM) and desoxypipradrol (2-DPMP). Clin Toxicol (Phila) 2012; 50:727–732
   PubMed Web of Science ®Google Scholar
• Wood DM, Davies S, Puchnaewicz M, Button J, Archer R, Ovaska H, et al. Recreational use of Mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 2010; 6:327–330.
   PubMedGoogle Scholar
• Bersani FS, Corazza O, Albano G, Valeriani G, Santacroce R, Bolzan Mariotti Posocco F, et al. 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. Biomed Res Int 2014: 734749.
   Google Scholar
• Corazza O, Schifano F, Simonato P, Fergus S, Assi S, Stair J, et al. Phenomenon of new drugs on the Internet: The case of ketamine derivative methoxetamine. Hum Psychopharmacol 2012; 27: 145–149.
   PubMed Web of Science ®Google Scholar
• Corkery JM, Elliott S, Schifano F, Corazza O, Ghodse AH. 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): a preliminary review. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39:253–258.
   PubMed Web of Science ®Google Scholar
• Corkery JM, Elliott S, Schifano F, Corazza O, Ghodse AH. MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; ‘sparkle’; ‘mindy’) toxicity: a brief overview and update. Hum Psychopharmacol 2013; 28:345–355.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Briefing paper: Online sales of new psychoactive substances/‘legal highs’: summary of results from the 2011 multilingual snapshots: Available from: www.emcdda.europa.eu/attachements.cfm/att.143801_EN_SnapshotSummary.pdf (Last accessed 17th September 2014).
   Google Scholar
• Hillebrand J, Olszewski D, Sedefov R. Legal highs on the Internet. Subst Use Misuse 2010; 45:330–340.
   PubMed Web of Science ®Google Scholar
• Bluelight forum. Available from: http://www.bluelight.org/vb/threads/640564-MT-45-(1-cyclohexyl-4-(1-2-diphenylethyl)piperazine) (Last accessed 17th September 2014).
   Google Scholar
• Shroomery forum. Available from: http://www.shroomery.org/forums/showflat.php/Number/18265612. (Last accessed 21st May 2014).
   Google Scholar
• UK Chemical Research forum. Available from: http://www.ukchemicalresearch.org/Thread-MT-45?page = 6 (Last accessed 21st May 2014)
   Google Scholar
• Helander A, Bäckberg M, Beck O. MT-45, a new psychoactive substance associated with hearing loss and unconsciousness. Clin Toxicol (Phila) 2014; 52:901–904.
   PubMed Web of Science ®Google Scholar
• US Immigration and Custom Enforcement. HSI seizes websites selling potentially deadly illegal narcotics. Available from: m.ice.gov/news/releases/1404/140411buffalo.htm?f = m (Last accessed 14th October 2014).
   Google Scholar
• EMCDDA-Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’). Available from: www.emcdda.europa.eu/attachements.cfm/att_230615_EN_TDAS14007ENN.pdf (Last accessed 14th October 2014).
   Google Scholar
• Measham F, Moore K, Newcombe R, Welch Z. Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition. Drugs Alcohol Today 2010; 10:14–21.
   Google Scholar
• Wood DM, Dargan PI. Using Internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance alpha-methyltryptamine (AMT). Subst Use Misuse 2013; 49:7–12.
   Web of Science ®Google Scholar
• Vermette-Marcotte A-E, Dargan PI, Archer JRH, Gosselin S, Wood DM. An Internet snapshot study to compare the international availability of the novel psychoactive substance methiopropamine. Clin Toxicol (Phila) 2014; 52:678–681.
   PubMed Web of Science ®Google Scholar
• Nizar H, Dargan PI, Wood DM. Using internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4,4’-dimethylaminorex. J Med Toxicol 2014; Epub ahead of print 29 Aug 2014 [DOI: 10.1007/s13181-014-0425-0].
   Google Scholar
• Dargan PI, Sedefov R, Gallegos A, Wood DM. The pharmacology and toxicology of the synthetic cathinone Mephedrone (4-methylmethcathinone). Drug Test Anal 2011; 3:454–463.
   PubMed Web of Science ®Google Scholar